Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology Average | - - | - - | - - | 14,002.46 | 875.63 | 219.40 | -128.53 | 38.07 | 0.03 | 1.1947 | -0.33 | -116.1574 | -2,552.5330 | -9.49 | -9.21 | 780.3405 | - - | ||
Maximum | - - | - - | - - | 593,737.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.94 | 701.8537 | 6.70 | 300.5100 | 8,534.8500 | 38.40 | 835.37 | 6,156.2100 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -10,177.5800 | -144,478.0000 | -155.91 | -1,263.79 | 0.0700 | - - | ||
Madrigal Pharmaceuticals, Inc. MDGL | 242.25 | 9.09 3.90% | 287 vs. 281 | 5,259.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.00 | 0.00 | 0.00 | -17.34 | -13.63 | 926.23 | 21.00 | ||
PTC Therapeutics, Inc. PTCT | 36.16 | 0.68 1.92% | 507 vs. 687 | 2,781.00 | 210.00 | -91.00 | 6.00 | -3,375.00 | -1.2000 | -5.9705 | 0.00 | 68.46 | -43.58 | 10.24 | -5.12 | 188.54 | 76.00 | ||
Karuna Therapeutics, Inc. KRTX | 329.83 | 0.09 0.03% | 1,283 vs. 971 | 12,599.00 | 0.00 | -113.00 | -111.00 | -997.00 | -3.0100 | -26.2644 | 0.00 | 0.00 | 0.00 | -9.08 | -8.52 | 1860.75 | 38.00 | ||
Blueprint Medicines Corporation BPMC | 90.94 | 1.61 1.80% | 674 vs. 688 | 5,760.00 | 96.00 | 89.00 | -102.00 | -2,250.00 | 1.4500 | 16.6530 | 0.00 | 91.68 | 92.74 | 28.69 | 8.58 | 342.66 | 63.00 | ||
Krystal Biotech, Inc. KRYS | 184.48 | 1.74 0.95% | 335 vs. 355 | 5,300.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.00 | 94.65 | 2.06 | 0.12 | 0.11 | 1228.70 | 28.00 | ||
IVERIC bio, Inc. ISEE | 39.95 | 0.15 0.38% | 10,801 vs. 4,945 | 5,512.00 | 0.00 | -70.00 | -50.00 | -937.00 | -0.5200 | -11.8078 | 0.00 | 0.00 | 0.00 | -14.80 | -11.51 | 1523.65 | 137.00 |